Top-Line Growth
Q1 2026 revenue increased to $705.2M from $604.6M in Q1 2025, a 17% year-over-year increase driven by new contracts and facility activations.
Profitability Expansion
Net income attributable to operations rose to $38.3M ($0.29/diluted share) vs. $19.6M ($0.14) in Q1 2025, a 96% year-over-year increase; adjusted EBITDA increased to $131.4M from $99.8M, a 32% increase.
Major New Business Wins
2025 contracts represent up to ~$520M in incremental annual revenue (the largest single-year wins in company history), including new/expanded ICE contracts and a five-year U.S. Marshals Service transportation contract (~$60M incremental annual revenue).
ISAP Technology and Mix Shift
ISAP enrollment remained stable at ~180-181K, with a material shift toward higher-priced monitoring: GPS ankle monitors increased to >48K (from 17K in early 2025) and case management assignments rose to ~111K, which the company expects to drive higher revenue/earnings even at stable volumes.
Secure Services Activation & Bed Capacity
Reactivated three previously idled company-owned facilities and Adelanto, adding ~6,000 beds for ICE reactivation; total beds under contract with ICE increased to ~26,000, representing over one-third of the national ICE population (~58,000).
Improved Operating Efficiency & G&A
Operating results benefited from lower-than-expected labor/overtime costs and G&A declined to 8.6% of revenue from 9.6% a year ago, contributing to margin improvement.
Capital Allocation & Balance Sheet Actions
Repurchased ~3.6M shares for ~$50M in Q1 (8.5M shares / ~$141M total repurchased year-to-date) with ~$359M remaining under the $500M authorization; expanded revolving credit facility by $100M; net leverage below 3.2x adjusted EBITDA.
Raised 2026 Guidance
Full-year 2026 guidance increased: GAAP net income $153M–$166M ($1.10–$1.25/sh), revenues $2.95B–$3.10B, adjusted EBITDA $525M–$545M; Q2 guidance provided (revenues $715M–$725M; adjusted EBITDA $130M–$135M).
New Service Contracts & State Wins
Secured a two-year ISAP 5 contract, a two-year skip tracing contract (began March, up to $60M/year), and two Florida DOC management-only contracts (~$100M combined annual revenues) beginning July 1, 2026.